Afya Forecast, price target & analysts
Afya Target price 2025 - Analyst rating & recommendation
Afya Classifications & Recommendation:
Afya Price Target
| Target Price | $20.04 |
| Price | $17.99 |
| Potential |
11.40%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Afya 2026 .
The average Afya target price is $20.04.
This is
11.40%
register free of charge
$24.87
38.27%
register free of charge
$16.21
9.88%
register free of charge
|
|
| A rating was issued by 9 analysts: 3 Analysts recommend Afya to buy, 2 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Afya stock has an average upside potential 2026 of
11.40%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 596.69 | 670.82 |
| 14.90% | 12.42% | |
| EBITDA Margin | 40.72% | 43.83% |
| 10.83% | 7.64% | |
| Net Margin | 19.11% | 21.35% |
| 42.28% | 11.71% |
8 Analysts have issued a sales forecast Afya 2025 . The average Afya sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Afya EBITDA forecast 2025. The average Afya EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Afya Analysts have issued a net profit forecast 2025. The average Afya net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.25 | 1.53 |
| 62.34% | 22.40% | |
| P/E | 11.77 | |
| EV/Sales | 2.98 |
4 Analysts have issued a Afya forecast for earnings per share. The average Afya EPS is
This results in the following potential growth metrics and future valuations:
Current Afya Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Jun 12 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jan 31 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jan 17 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Dec 03 2024 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 30 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Jun 12 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jan 31 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jan 17 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Dec 03 2024 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 30 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
